Home › Blood Cancers › Louisiana
Blood Cancers clinical trials in Louisiana
6 studies for Blood Cancers are looking for participants at sites in Louisiana.
Cities in Louisiana
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- LSU Health Baton Rouge-North Clinic, Baton Rouge
- Our Lady of the Lake Physician Group, Baton Rouge
- Our Lady of the Lake Medical Oncology, Baton Rouge
- and 3 more
RecruitingObservational study
All ages · All sexes · Updated Oct 5, 2026 · NCT04242095Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
- Women's Cancer Care ( Site 0088), Covington
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT03486873Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- LSU Health Baton Rouge-North Clinic, Baton Rouge
- Our Lady of the Lake Physician Group, Baton Rouge
- Our Lady of The Lake, Baton Rouge
- and 7 more
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Children's Hospital of New Orleans/LSUHSC, New Orleans
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
- Children's Hospital New Orleans, New Orleans
RecruitingPhase 3
Ages 2 to 18 · All sexes · Updated May 5, 2026 · NCT05711667A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
- Ochsner MD Anderson Cancer Center, Jefferson
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Mar 13, 2026 · NCT05735184From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.